Skip to main content
. Author manuscript; available in PMC: 2015 Jun 14.
Published in final edited form as: J Am Coll Cardiol. 2014 Jul 15;64(2):119–125. doi: 10.1016/j.jacc.2014.04.035

TABLE 2.

Predictors of Ventricular Arrhythmias in the 108 Patients With ICDs

Clinical Characteristics No Arrhythmia (n = 60) Arrhythmia (n = 48) p Value
Age at enrollment, yrs 41 ± 14 38 ± 14 0.413
Age at earliest symptom, yrs 37 ± 14 35 ± 15 0.609
Female 27 (45) 16 (33) 0.218
Affected (by Task Force Criteria) 37 (62) 40 (83) 0.013
Diagnostic criteria points (1994 criteria) 4.2 ± 1.0 4.3 ± 1.2 0.84
Arrhythmic events (VT/VF) before enrollment 34 (57) 45 (94) <0.001
Syncope before enrollment 14 (23) 14 (29) 0.492
Syncope or VT/VF before enrollment 36 (60) 46 (96) <0.001
Family history of sudden death 22 (42) 16 (36) 0.960
Follow-up, yrs 3.0 ± 1.8 3.5 ± 1.5 0.114
Heart transplant 2 (3) 1 (2) 1.000
Death 1 (2) 1 (2) 1.000
Antiarrhythmic drug treatment 19 (39) 34 (72) <0.001
Beta-blockers 41 (84) 39 (83) 0.927
RVEF (%) by MRI, mean 43 ± 11 43 ± 13 0.334
LVEF (%) by MRI, mean 59.74 ± 6.42 55.65 ± 4.79 0.009
Negative T-wave in leads II, III, aVF 19 (32) 33 (69) <0.001
QRS duration in V2, mean 0.103 ± 0.023 0.108 ± 0.021 0.055
fQRS40, mean 116.9 126.5 0.011
fQRS40 >120 16 (33) 21 (55) 0.041
VPBs (ventricular total >1,000/24 h) 25 (58) 18 (51) 0.553
Any induced VT or VF 30 (50) 33 (69) 0.050

Values are mean ± SD or n (%). Predictors of arrhythmias after ICD implantation included definite diagnosis of ARVC, VT/VF before enrollment, syncope or VT/VF before enrollment, antiarrhythmic drug treatment, negative T-wave in leads II, III, aVF, abnormal SAECG by fQRS40 mean and >140 ms, induced VT/VF. The 2 independent predictors of ICD treatment of ventricular arrhythmias were pre-implantation sustained VT/VF (p = 0.0029) and T-wave inversions inferiorly (p = 0.0159).

EPS = electrophysiologic study; VPB = ventricular premature beat; VF = ventricular fibrillation; other abbreviations as in Table 1.